High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience ; volume:58 ; number:11 ; day:23 ; month:8 ; year:2023 ; pages:1229-1236 ; date:11.2023
Bone marrow transplantation ; 58, Heft 11 (23.8.2023), 1229-1236, 11.2023
- Urheber
-
Kabut, Tomáš
Weinbergerová, Barbora
Folber, František
Lengerová, Martina
Mayer, Jiří
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41409-023-02081-6
- URN
-
urn:nbn:de:101:1-2024012210520026732784
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kabut, Tomáš
- Weinbergerová, Barbora
- Folber, František
- Lengerová, Martina
- Mayer, Jiří
- SpringerLink (Online service)
Ähnliche Objekte (12)
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity
High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation
Cytomegalievirus (CMV)-Primärinfektion und kongenitale CMV (cCMV)-Infektion in Sachsen-Anhalt
Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients
Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms
Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity
High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation
Cytomegalievirus (CMV)-Primärinfektion und kongenitale CMV (cCMV)-Infektion in Sachsen-Anhalt
Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients
Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms
Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data
Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity
High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation
Cytomegalievirus (CMV)-Primärinfektion und kongenitale CMV (cCMV)-Infektion in Sachsen-Anhalt
Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients
Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms